Treatment(s) already received-Lumpectomy Page 2 Posts on Medivizor
Navigation Menu

Treatment(s) already received-Lumpectomy Posts on Medivizor

The influence of infection on breast cancer recurrence following breast reconstruction

Posted by on Mar 21, 2016 in Breast cancer | 0 comments

In a nutshell The authors aimed to assess the influence of possible infections following breast reconstruction on the risks of breast cancer recurrence. This study showed that post-operative complications or infections had a significant impact on the rates of breast cancer recurrence. Some background Breast reconstruction surgery is a procedure...

Read More

Breast cancer; what are the risks of cancer returning following surgery?

Posted by on Jun 24, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to assess the overall risks of breast cancer recurrence (return of the cancer) following two types of breast cancer surgery. Some background Breast cancer treatments may include surgery; a mastectomy is the removal of the entire breast while breast-conserving surgery is the removal of the breast cancer but not the...

Read More

Cancer sub-types; what are the characteristics?

Posted by on Jun 24, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to distinguish whether the characteristics of breast cancer could depend on the focality of the tumor. Some background Breast cancer can be characterized as 'unifocal', 'multifocal and 'multicentric'. This refers to the number of areas in which the cancer can be found (focality); unifocal...

Read More

Radiation to the lymph nodes in stage II and II breast cancer; is it necessary?

Posted by on Jun 11, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to assess the effectiveness of radiotherapy treatment (uses high-energy radiation to kill cancer cells by damaging their DNA) on women with breast cancer who have previously had surgery. Some background Breast- conserving surgery (removes the breast cancer but not the breast itself) is just one method of breast...

Read More

Breast cancer in premenopausal women; hormone treatment with ovarian suppression

Posted by on Jun 5, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to determine the effectiveness of exemestane (Aromasin) to treat premenopausal women with breast cancer and treatment outlook in comparison to tamoxifen (Nolvadex). Some background Tamoxifen is a type of hormone therapy used to treat breast cancer. This type of treatment is generally specific for hormone receptor...

Read More

Cancer spread; do age and tumor type affect the risk?

Posted by on May 21, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to determine if there was a link between patient age, tumor type and the spread of cancer.  Some background Breast cancer metastasis is the spread of the cancer to other parts of the body; following original cancer of the breast. Age at original diagnosis and the area affected by the tumor are just two of the...

Read More

Treatment for breast cancer patients with depression

Posted by on May 19, 2015 in Breast cancer | 1 comment

In a nutshell This article evaluated the benefits of psychology treatments for breast cancer patients with depression. Some background Many women with breast cancer also suffer from depression (22%). This can lead to a decreased quality of life and overall prognosis (treatment outcome). 'Psychodynamic psychotherapy' is a form of...

Read More

Should you get a second sentinel lymph node biopsy?

Posted by on Feb 18, 2015 in Breast cancer | 0 comments

In a nutshell This paper studied whether having a second sentinel lymph node biopsy (removal of tissue from the lymph node to assess for cancer cells) is beneficial for patients who have recurred despite a negative first sentinel lymph node biopsy and conservative surgery. Some background Sentinel lymph node biopsy is a procedure where the first...

Read More

What is the effect of ending trastuzumab treatment early in older breast cancer patients?

Posted by on Jan 26, 2015 in Breast cancer | 0 comments

In a nutshell This paper evaluated early discontinuation of trastuzumab (Herceptin) therapy and how cardiovascular events (disease associated with the heart and blood vessels) associated with this affect survival in older women with breast cancer. Some background Human epidermal growth factor receptor 2 (HER2) is a protein that can be found...

Read More